CFO
ALXN

CVA Family Office’s Alexion Pharmaceuticals ALXN Stock Holding History

CVA Family Office’s Portfolio ALXN Stock Details ALXN Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
2021
Q3 		$11K Sell
2021
Q2 		$45K Buy
2021
Q1 		$37K Buy
2020
Q4 		$16K Hold
2020
Q3 		$11K Hold
2020
Q2 		$11K Hold
2020
Q1 		$9K Buy